Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gelfond

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|April 20, 2022
Changes in Glucose Breath Test in Cystic Fibrosis Patients Treated With 1 Month of Lumacaftor/IvacaftorMegan E Gabel, Hongyue Wang, Daniel Gelfond, et al.
Health Physics|August 30, 2012
The acute gastrointestinal subsyndrome of the acute radiation syndrome: a rhesus macaque modelThomas J MacVittie, Ann M Farese, Alexander Bennett, et al.
Annals of Medicine|September 28, 2010
Natural history of celiac disease autoimmunity in a USA cohort followed since 1974Carlo Catassi, Debby Kryszak, Bushra Bhatti, et al.
Clinical and Translational Science|June 9, 2015
Standardization of Research-Quality Anthropometric Measurement of Infants and Implementation in a Multicenter StudyChristine Coburn-Miller, Susan Casey, Quynh Luong, et al.
Health Physics|August 30, 2012
The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiationThomas J MacVittie, Alexander Bennett, Catherine Booth, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 21, 2021
Gastrointestinal Factors Associated With Hospitalization in Infants With Cystic Fibrosis: Results From the Baby Observational and Nutrition StudyMeghana Sathe, Rong Huang, Sonya Heltshe, et al.
Annals of the American Thoracic Society|July 10, 2020
Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical TrialScott D Sagel, Umer Khan, Sonya L Heltshe, et al.
Clinical and Translational Gastroenterology|March 17, 2017
Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D MutationDaniel Gelfond, Sonya Heltshe, Changxing Ma, et al.
American Journal of Respiratory and Critical Care Medicine|June 14, 2014
Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosisSteven M Rowe, Sonya L Heltshe, Tanja Gonska, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2026
Longitudinal changes in bone mineral density after initiation of elexacaftor-tezacaftor-ivacaftor in youth and adults with cystic fibrosis: PROMISE-ENDOMeghan Shirley Bezerra, Babette S Zemel, Robert J Gallop, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Gastroenterology and Nutrition|April 20, 2022
Changes in Glucose Breath Test in Cystic Fibrosis Patients Treated With 1 Month of Lumacaftor/IvacaftorMegan E Gabel, Hongyue Wang, Daniel Gelfond, et al.
Health Physics|August 30, 2012
The acute gastrointestinal subsyndrome of the acute radiation syndrome: a rhesus macaque modelThomas J MacVittie, Ann M Farese, Alexander Bennett, et al.
Annals of Medicine|September 28, 2010
Natural history of celiac disease autoimmunity in a USA cohort followed since 1974Carlo Catassi, Debby Kryszak, Bushra Bhatti, et al.
Clinical and Translational Science|June 9, 2015
Standardization of Research-Quality Anthropometric Measurement of Infants and Implementation in a Multicenter StudyChristine Coburn-Miller, Susan Casey, Quynh Luong, et al.
Health Physics|August 30, 2012
The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiationThomas J MacVittie, Alexander Bennett, Catherine Booth, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 21, 2021
Gastrointestinal Factors Associated With Hospitalization in Infants With Cystic Fibrosis: Results From the Baby Observational and Nutrition StudyMeghana Sathe, Rong Huang, Sonya Heltshe, et al.
Annals of the American Thoracic Society|July 10, 2020
Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical TrialScott D Sagel, Umer Khan, Sonya L Heltshe, et al.
Clinical and Translational Gastroenterology|March 17, 2017
Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D MutationDaniel Gelfond, Sonya Heltshe, Changxing Ma, et al.
American Journal of Respiratory and Critical Care Medicine|June 14, 2014
Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosisSteven M Rowe, Sonya L Heltshe, Tanja Gonska, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2026
Longitudinal changes in bone mineral density after initiation of elexacaftor-tezacaftor-ivacaftor in youth and adults with cystic fibrosis: PROMISE-ENDOMeghan Shirley Bezerra, Babette S Zemel, Robert J Gallop, et al.
Pageof 4